Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Constantinescu

Showing results (131-140 of 180) with videos related to

Pageof 18
Sort By:
Elife|June 20, 2023
Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimersJean-Philippe Defour, Emilie Leroy, Sharmila Dass, et al.
The Journal of Experimental Medicine|July 22, 2009
An activating mutation in the CSF3R gene induces a hereditary chronic neutrophiliaIsabelle Plo, Yanyan Zhang, Jean-Pierre Le Couédic, et al.
Nature Communications|April 5, 2023
Oncogenic CALR mutant C-terminus mediates dual binding to the thrombopoietin receptor triggering complex dimerization and activationNicolas Papadopoulos, Audrey Nédélec, Allison Derenne, et al.
Blood|August 22, 2014
JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiationRodolphe Besancenot, Damien Roos-Weil, Carole Tonetti, et al.
Blood|December 1, 2017
Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALLSandrine Degryse, Simon Bornschein, Charles E de Bock, et al.
The Journal of Biological Chemistry|January 19, 2008
Amyloidogenic processing but not amyloid precursor protein (APP) intracellular C-terminal domain production requires a precisely oriented APP dimer assembled by transmembrane GXXXG motifsPascal Kienlen-Campard, Bernadette Tasiaux, Joanne Van Hees, et al.
Blood|May 19, 2021
CALR mutant protein rescues the response of MPL p.R464G variant associated with CAMT to eltrombopagFrancesca Basso-Valentina, Gabriel Levy, Leila N Varghese, et al.
Blood|November 2, 2022
Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosisSara Lecomte, Julien Devreux, Grégoire de Streel, et al.
Clinical Chemistry and Laboratory Medicine|October 16, 2020
A biological profile for diagnosis and outcome of COVID-19 patientsMehdi Khourssaji, Virginie Chapelle, Anton Evenepoel, et al.
Nature Communications|September 28, 2020
Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPNCamélia Benlabiod, Maira da Costa Cacemiro, Audrey Nédélec, et al.
Pageof 18

Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
Elife|June 20, 2023
Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimersJean-Philippe Defour, Emilie Leroy, Sharmila Dass, et al.
The Journal of Experimental Medicine|July 22, 2009
An activating mutation in the CSF3R gene induces a hereditary chronic neutrophiliaIsabelle Plo, Yanyan Zhang, Jean-Pierre Le Couédic, et al.
Nature Communications|April 5, 2023
Oncogenic CALR mutant C-terminus mediates dual binding to the thrombopoietin receptor triggering complex dimerization and activationNicolas Papadopoulos, Audrey Nédélec, Allison Derenne, et al.
Blood|August 22, 2014
JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiationRodolphe Besancenot, Damien Roos-Weil, Carole Tonetti, et al.
Blood|December 1, 2017
Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALLSandrine Degryse, Simon Bornschein, Charles E de Bock, et al.
The Journal of Biological Chemistry|January 19, 2008
Amyloidogenic processing but not amyloid precursor protein (APP) intracellular C-terminal domain production requires a precisely oriented APP dimer assembled by transmembrane GXXXG motifsPascal Kienlen-Campard, Bernadette Tasiaux, Joanne Van Hees, et al.
Blood|May 19, 2021
CALR mutant protein rescues the response of MPL p.R464G variant associated with CAMT to eltrombopagFrancesca Basso-Valentina, Gabriel Levy, Leila N Varghese, et al.
Blood|November 2, 2022
Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosisSara Lecomte, Julien Devreux, Grégoire de Streel, et al.
Clinical Chemistry and Laboratory Medicine|October 16, 2020
A biological profile for diagnosis and outcome of COVID-19 patientsMehdi Khourssaji, Virginie Chapelle, Anton Evenepoel, et al.
Nature Communications|September 28, 2020
Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPNCamélia Benlabiod, Maira da Costa Cacemiro, Audrey Nédélec, et al.
Pageof 18